US OptionsDetailed Quotes
MDT240719C86000
- 0.07
- 0.000.00%
15min DelayTrading Jul 17 13:09 ET
0.00High0.00Low
0.00Open0.07Pre Close0 Volume23 Open Interest86.00Strike Price0.00Turnover41.07%IV4.29%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type0.0991Delta0.0769Gamma786.00Leverage Ratio-0.0962Theta0.0004Rho77.92Eff Leverage0.0096Vega
Medtronic Stock Discussion
Sign in to post a comment
$Chevron(CVX.US$
One of the U.S.’s largest energy corporations, Chevron Corporation (NYSE:CVX) specializes in oil, gas and renewable fuels. The company has upstream and downstream operations focused on the oil and gas industry. Oil companies are an interesting pick since the best ones are known for paying dividends, even in bad times.
Chevron has a 37-year history of increasing dividends and has consistently paid them since ...
One of the U.S.’s largest energy corporations, Chevron Corporation (NYSE:CVX) specializes in oil, gas and renewable fuels. The company has upstream and downstream operations focused on the oil and gas industry. Oil companies are an interesting pick since the best ones are known for paying dividends, even in bad times.
Chevron has a 37-year history of increasing dividends and has consistently paid them since ...
33
3
Morning Movers
Gapping up
$NVIDIA(NVDA.US$ stock soared over 7% after the company's first-quarter earnings exceeded expectations, boosted by a strong AI industry demand. Nvidia's success also positively influenced its peers, with $Advanced Micro Devices(AMD.US$ and $Broadcom(AVGO.US$ each gaining over 2%, while $Micron Technology(MU.US$ rose 3.8%, and chip designer $Arm Holdings(ARM.US$ nearly 4%.
$News Corp-B(NWS.US$ shar...
Gapping up
$NVIDIA(NVDA.US$ stock soared over 7% after the company's first-quarter earnings exceeded expectations, boosted by a strong AI industry demand. Nvidia's success also positively influenced its peers, with $Advanced Micro Devices(AMD.US$ and $Broadcom(AVGO.US$ each gaining over 2%, while $Micron Technology(MU.US$ rose 3.8%, and chip designer $Arm Holdings(ARM.US$ nearly 4%.
$News Corp-B(NWS.US$ shar...
33
4
» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings(CERE.US$
$Amicus Therapeutics(FOLD.US$
$Iovance Biotherapeutics(IOVA.US$
$Arcellx(ACLX.US$
$Nuvalent(NUVL.US$
$Apogee Therapeutics(APGE.US$
$Inhibrx(INBX.US$
$Fusion Pharmaceuticals(FUSN.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Vaxcyte(PCVX.US$
$Soleno Therapeutics(SLNO.US$
$Medtronic(MDT.US$
$Madrigal Pharmaceuticals(MDGL.US$
...
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings(CERE.US$
$Amicus Therapeutics(FOLD.US$
$Iovance Biotherapeutics(IOVA.US$
$Arcellx(ACLX.US$
$Nuvalent(NUVL.US$
$Apogee Therapeutics(APGE.US$
$Inhibrx(INBX.US$
$Fusion Pharmaceuticals(FUSN.US$
$Rhythm Pharmaceuticals(RYTM.US$
$Vaxcyte(PCVX.US$
$Soleno Therapeutics(SLNO.US$
$Medtronic(MDT.US$
$Madrigal Pharmaceuticals(MDGL.US$
...
8
Bridgewater's Holdings Report
Significant Increases: $Alphabet-A(GOOGL.US$ , $NVIDIA(NVDA.US$ , $Apple(AAPL.US$ , $Meta Platforms(META.US$ , $Microsoft(MSFT.US$
New Positions: $Amazon(AMZN.US$ , $Advanced Micro Devices(AMD.US$
Specific Holdings Changes
Amazon: Largest new position, acquired nearly 1.05 million shares worth $189 million
AMD: Chipmaker, acquired nearly 680,000 shares worth $123 million
$Medtronic(MDT.US$ : Medical technology leader, a...
Significant Increases: $Alphabet-A(GOOGL.US$ , $NVIDIA(NVDA.US$ , $Apple(AAPL.US$ , $Meta Platforms(META.US$ , $Microsoft(MSFT.US$
New Positions: $Amazon(AMZN.US$ , $Advanced Micro Devices(AMD.US$
Specific Holdings Changes
Amazon: Largest new position, acquired nearly 1.05 million shares worth $189 million
AMD: Chipmaker, acquired nearly 680,000 shares worth $123 million
$Medtronic(MDT.US$ : Medical technology leader, a...
6
Morning Movers
Gapping up
$Medtronic(MDT.US$ on Tuesday raised its annual profit forecast for the third time this fiscal, banking on higher demand for its medical devices, sending the company's shares up 6% in premarket trading. The company also said it has decided to exit its unprofitable ventilator product line but would continue to honor existing ventilator contracts.
Medtronic expects adjusted profit for the fiscal 2024 to ...
Gapping up
$Medtronic(MDT.US$ on Tuesday raised its annual profit forecast for the third time this fiscal, banking on higher demand for its medical devices, sending the company's shares up 6% in premarket trading. The company also said it has decided to exit its unprofitable ventilator product line but would continue to honor existing ventilator contracts.
Medtronic expects adjusted profit for the fiscal 2024 to ...
19
1
Cowen analyst Joshua Jennings remains positive about Medtronic's growth, despite recent revenue downgrades. The company's earnings results saw only one downward revision and 17 upward revisions.
1
Medtronic's optimistic 2024 prediction is driven by mitigated recession concerns, a perception of lower rates, and growth within the sector. Analysts have varying levels of confidence with some predicting the stock will even out once economy stabilizes.
Morning Movers
Gapping up
$Agilent Technologies(A.US$ stock rose 6.7% after the healthcare equipment provider beat expectations in its fourth quarter, despite what CEO Mike McMullen called a “challenging year for the industry.”
$Medtronic(MDT.US$ stock rose 2.2% after the medical device manufacturer raised its annual revenue and earnings outlook following "broad-based, diversified" growth in its fiscal second quarter.
$Symbotic(SYM.US$ stock soa...
Gapping up
$Agilent Technologies(A.US$ stock rose 6.7% after the healthcare equipment provider beat expectations in its fourth quarter, despite what CEO Mike McMullen called a “challenging year for the industry.”
$Medtronic(MDT.US$ stock rose 2.2% after the medical device manufacturer raised its annual revenue and earnings outlook following "broad-based, diversified" growth in its fiscal second quarter.
$Symbotic(SYM.US$ stock soa...
14
1
Doubts on new Medicare drug pricing scheme, disapproval of pharma mergers, and low dividend yields are hitting the sector. Even if Johnson & Johnson settles talc suits, investors are wary of JNJ, Abbott Labs and Medtronic due to potential impact of new obesity drugs on device sales.
1
No comment yet
101550592 :
102188459 : Tq
Paul Anthony Chin : very good test for myself first and second give your best price for your wonderful family together with this tq God bless All rights reserved to Babylon Amen
